Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia.
N Engl J Med. 2016 Jan 28;374(4):323-32. doi: 10.1056/NEJMoa1509981. Epub 2015 Dec 7.
N Engl J Med. 2016.
PMID: 26641137
Free PMC article.
Clinical Trial.
Preclinical Evaluation of the Novel BTK Inhibitor Acalabrutinib in Canine Models of B-Cell Non-Hodgkin Lymphoma.
Harrington BK, Gardner HL, Izumi R, Hamdy A, Rothbaum W, Coombes KR, Covey T, Kaptein A, Gulrajani M, Van Lith B, Krejsa C, Coss CC, Russell DS, Zhang X, Urie BK, London CA, Byrd JC, Johnson AJ, Kisseberth WC.
Harrington BK, et al. Among authors: rothbaum w.
PLoS One. 2016 Jul 19;11(7):e0159607. doi: 10.1371/journal.pone.0159607. eCollection 2016.
PLoS One. 2016.
PMID: 27434128
Free PMC article.
Clinical Trial.
Item in Clipboard
Acalabrutinib in relapsed or refractory mantle cell lymphoma (ACE-LY-004): a single-arm, multicentre, phase 2 trial.
Wang M, Rule S, Zinzani PL, Goy A, Casasnovas O, Smith SD, Damaj G, Doorduijn J, Lamy T, Morschhauser F, Panizo C, Shah B, Davies A, Eek R, Dupuis J, Jacobsen E, Kater AP, Le Gouill S, Oberic L, Robak T, Covey T, Dua R, Hamdy A, Huang X, Izumi R, Patel P, Rothbaum W, Slatter JG, Jurczak W.
Wang M, et al. Among authors: rothbaum w.
Lancet. 2018 Feb 17;391(10121):659-667. doi: 10.1016/S0140-6736(17)33108-2. Epub 2017 Dec 11.
Lancet. 2018.
PMID: 29241979
Free PMC article.
Clinical Trial.
Item in Clipboard
Acalabrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia: updated phase 2 results.
Byrd JC, Wierda WG, Schuh A, Devereux S, Chaves JM, Brown JR, Hillmen P, Martin P, Awan FT, Stephens DM, Ghia P, Barrientos J, Pagel JM, Woyach JA, Burke K, Covey T, Gulrajani M, Hamdy A, Izumi R, Frigault MM, Patel P, Rothbaum W, Wang MH, O'Brien S, Furman RR.
Byrd JC, et al. Among authors: rothbaum w.
Blood. 2020 Apr 9;135(15):1204-1213. doi: 10.1182/blood.2018884940.
Blood. 2020.
PMID: 31876911
Free PMC article.
Clinical Trial.
Item in Clipboard
Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial.
Byrd JC, Hillmen P, Ghia P, Kater AP, Chanan-Khan A, Furman RR, O'Brien S, Yenerel MN, Illés A, Kay N, Garcia-Marco JA, Mato A, Pinilla-Ibarz J, Seymour JF, Lepretre S, Stilgenbauer S, Robak T, Rothbaum W, Izumi R, Hamdy A, Patel P, Higgins K, Sohoni S, Jurczak W.
Byrd JC, et al. Among authors: rothbaum w.
J Clin Oncol. 2021 Nov 1;39(31):3441-3452. doi: 10.1200/JCO.21.01210. Epub 2021 Jul 26.
J Clin Oncol. 2021.
PMID: 34310172
Free PMC article.
Clinical Trial.
Item in Clipboard
BOREAS: a global, phase III study of the MDM2 inhibitor navtemadlin (KRT-232) in relapsed/refractory myelofibrosis.
Verstovsek S, Al-Ali HK, Mascarenhas J, Perkins A, Vannucchi AM, Mohan SR, Scott BL, Woszczyk D, Koschmieder S, García-Delgado R, László R, McGreivy JS, Rothbaum WP, Kiladjian JJ.
Verstovsek S, et al. Among authors: rothbaum wp.
Future Oncol. 2022 Nov 23. doi: 10.2217/fon-2022-0901. Online ahead of print.
Future Oncol. 2022.
PMID: 36416118
Free article.
Review.
Item in Clipboard
Zanubrutinib in Chronic Lymphocytic Leukemia.
Byrd JC, Rothbaum W.
Byrd JC, et al. Among authors: rothbaum w.
N Engl J Med. 2023 May 4;388(18):1719-1720. doi: 10.1056/NEJMc2302350.
N Engl J Med. 2023.
PMID: 37133595
No abstract available.
Item in Clipboard
Cite
Cite